Bachem Mourns the Passing of Founder Peter Grogg

Bachem Holding AG ( (CH:BANB) ) has issued an update.

Bachem mourns the loss of its founder, Dr. h.c. Peter Grogg, who passed away at 83. Grogg, who founded the company in 1971, was instrumental in transforming Bachem into a world leader in peptide synthesis, leaving a significant mark on the firm and Swiss economic history. His leadership spanned over three decades, during which he served as CEO and later as chairman of the board. The announcement highlights the deep impact Grogg had on Bachem’s operations and its standing in the industry.

The most recent analyst rating on (CH:BANB) stock is a Buy with a CHF100.00 price target. To see the full list of analyst forecasts on Bachem Holding AG stock, see the CH:BANB Stock Forecast page.

More about Bachem Holding AG

Bachem is a leading, innovation-driven company specializing in the development and manufacture of peptides and oligonucleotides. It provides pharmaceutical and biotechnology companies worldwide with products for research, clinical development, and commercial application. Headquartered in Switzerland, Bachem operates internationally with locations in Europe, the USA, and Asia.

Average Trading Volume: 144,181

Current Market Cap: CHF3.77B

Find detailed analytics on BANB stock on TipRanks’ Stock Analysis page.